1/4/2022 8:07:44 AM
Waylivra Gets Innovative Drug Category Pricing To Treat Familial Chylomicronemia Syndrome In Brazil
10/14/2021 8:32:46 AM
PTC Therapeutics Reports Opening Of Gene Therapy Manufacturing Facility In Hopewell, N.J.
10/11/2021 8:18:29 AM
PTC Therapeutics: Tegsedi Gets Category 1 Classification From CMED In Brazil
9/29/2021 8:06:39 AM
PTC Therapeutics: Results Show Improvements In Children With AADC Deficiency Treated With PTC-AADC Gene Therapy
9/20/2021 8:38:25 AM
PTC Therapeutics : Data Show Translarna Delays Loss Of Ambulation By Over 5yrs In Boys With NmDMD
6/9/2021 8:13:50 AM
PTC Therapeutics Elects Mary Smith To Board
5/26/2021 8:11:13 AM
PTC Therapeutics: FDA And EC Grant Orphan Drug Designation For PTC923 For Patients With Hyperphenylalaninemia
5/17/2021 9:38:09 AM
PTC Therapeuti : New Data Shows Devastating Impact Of AADC Deficiency On Caregivers
3/30/2021 1:02:11 AM
PTC Therapeutics: European Commission Grants Marketing Authorization To Evrysdi For Spinal Muscular Atrophy
3/9/2021 8:11:17 AM
SMA Foundation And PTC Expand Partnership To Advance Drug Discovery And Development Research In Regenerative Medicine
2/26/2021 6:57:44 AM
CHMP Adopts Positive Opinion For Evrysdi For Spinal Muscular Atrophy In Adults And Children Aged Two Months And Older